Can one predict, which Patients benefit from an outpatient cardiovascular Rehabilitation?

被引：0
|
作者：
Sartori, S. [1 ]
Charwat-Resl, S. [1 ]
Kellermair, J. [1 ]
Weber, T. [1 ]
Eber, B. [1 ]
机构：
[1] Klinikum Wels, Abt Kardiol, Wels, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2014年 / 126卷 / 17-18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P43
引用
收藏
页码：576 / 576
页数：1
相关论文
共 50 条
  • [31] The question is, which patients benefit from albumin
    Luckner, G.
    Jochberger, Stefan
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (50) : 2821 - 2821
  • [32] Which patients benefit from treatment? Reply
    Heiskanen, Tarja
    Roine, Risto P.
    Kalso, Eija
    SCANDINAVIAN JOURNAL OF PAIN, 2013, 4 (01) : 54 - 54
  • [33] Which Patients benefit from a PFO Closure?
    不详
    AKTUELLE NEUROLOGIE, 2014, 41 (05) : E64 - E64
  • [34] Which patients benefit from regional anaesthesia?
    Poyser, Thomas
    Murugesan, Sailakshmi
    Smith, Andrew
    CURRENT OPINION IN ANESTHESIOLOGY, 2016, 29 (05) : 620 - 625
  • [35] Can older patients with cognitive impairment benefit from geriatric day hospital (GDH) rehabilitation?
    Luk, J. K. H.
    Chan, F. H. W.
    Chu, L. W.
    AUSTRALASIAN JOURNAL ON AGEING, 2012, 31 : 37 - 37
  • [36] Can we predict which patients are at risk of fluoropyrimidines cardiotoxicity?
    Lestuzzi, C.
    Tartuferi, L.
    Viel, E.
    Virdone, S.
    Vaccher, E.
    Spazzapan, S.
    De Paoli, A.
    Buonadonna, A.
    Lleshi, A.
    Bidoli, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 703 - 703
  • [37] CAN WE PREDICT WHICH PATIENTS WILL SIGN AN INFORMED CONSENT
    DELUCA, SA
    ROUSE, CL
    KORCUSKA, LA
    OBERSTAR, BH
    WELSH, PA
    CIRCULATION, 1993, 88 (04) : 337 - 337
  • [38] Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?
    Goldman, Howard B.
    Oelke, Matthias
    Kaplan, Steven A.
    Kitta, Tekeya
    Russell, David
    Carlsson, Martin
    Arumi, Daniel
    Mangan, Erin
    Ntanios, Fady
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 (02) : 239 - 244
  • [39] IS IT POSSIBLE TO PREDICT WHICH PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WILL DERIVE RHEUMATOLOGICAL BENEFIT FROM STATIN THERAPY?
    McCarey, D. W.
    Sattar, N.
    Hampson, R.
    Madhok, R.
    McInnes, I. B.
    Capell, H. A.
    RHEUMATOLOGY, 2004, 43 : 45 - 45
  • [40] Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?
    Howard B. Goldman
    Matthias Oelke
    Steven A. Kaplan
    Tekeya Kitta
    David Russell
    Martin Carlsson
    Daniel Arumi
    Erin Mangan
    Fady Ntanios
    International Urogynecology Journal, 2019, 30 : 239 - 244
12345